Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Oncology Research|November 24, 2004
In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316Emmanuelle J Meuillet, Nathan Ihle, Amanda F Baker, et al.Investigative Radiology|June 23, 2020
Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal AdenocarcinomaRakesh Bam, Iman Daryaei, Lotfi Abou-Elkacem, et al.Journal of the American Chemical Society|December 17, 2009
Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazineKatherine M Block, Hui Wang, Lajos Z Szabó, et al.Cancer Research|June 4, 2009
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKTSylvestor A Moses, M Ahad Ali, Song Zuohe, et al.Molecular Cancer Therapeutics|May 14, 2009
NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1)Thomas S Dexheimer, Steven S Carey, Song Zuohe, et al.Molecular Cancer Therapeutics|September 16, 2008
Discovery of a novel class of AKT pleckstrin homology domain inhibitorsDaruka Mahadevan, Garth Powis, Eugene A Mash, et al.Molecular Cancer Therapeutics|March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitorEmmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.Cancer Research|May 2, 2019
An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and TumorsMartin Indarte, Roisin Puentes, Marco Maruggi, et al.Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.Journal of Cancer Prevention|April 12, 2021
Meeting Report: Translational Advances in Cancer Prevention Agent Development MeetingMark Steven Miller, Peter J Allen, Powel H Brown, et al.Pageof 5